These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27558854)

  • 1. Low-Dose Aripiprazole Augmentation in Amitriptyline-Resistant Burning Mouth Syndrome: Results from Two Cases.
    Takenoshita M; Motomura H; Toyofuku A
    Pain Med; 2017 Apr; 18(4):814-815. PubMed ID: 27558854
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-Dose Aripiprazole Augmentation in the Treatment of Burning Mouth Syndrome: A Case Report.
    Uzun Ö; Bolu A
    Clin Neuropharmacol; 2020; 43(3):92. PubMed ID: 32217865
    [No Abstract]   [Full Text] [Related]  

  • 3. An increase in salivary flow with amitriptyline may indicate treatment resistance in burning mouth syndrome.
    Kawasaki K; Nagamine T; Watanabe T; Suga T; Tu TTH; Sugawara S; Mikuzuki L; Miura A; Shinohara Y; Yoshikawa T; Takenoshita M; Toyofuku A
    Asia Pac Psychiatry; 2018 Sep; 10(3):e12315. PubMed ID: 29575764
    [No Abstract]   [Full Text] [Related]  

  • 4. Pain-relieving effects of clonazepam and amitriptyline in burning mouth syndrome: a retrospective study.
    Fenelon M; Quinque E; Arrive E; Catros S; Fricain JC
    Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1505-1511. PubMed ID: 28473243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked response of burning mouth syndrome to pregabalin treatment.
    López V; Alonso V; Martí N; Calduch L; Jordá E
    Clin Exp Dermatol; 2009 Oct; 34(7):e449-50. PubMed ID: 19747308
    [No Abstract]   [Full Text] [Related]  

  • 6. [Low doses of prazosin potantiates the antinociceptive/analgesic effect of amitriptyline].
    Büyükşekerci M; Gültekin H
    Agri; 2005 Jan; 17(1):54-6. PubMed ID: 15791502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of xerostomia in burning mouth syndrome: a case-control study.
    Silva LA; Siqueira JT; Teixeira MJ; Siqueira SR
    Arq Neuropsiquiatr; 2014 Feb; 72(2):91-8. PubMed ID: 24604360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy in relieving the symptoms of burning mouth syndrome: A 1-year follow-up study.
    Paudel D; Utsunomiya M; Yoshida K; Giri S; Uehara O; Matsuoka H; Chiba I; Toyofuku A; Abiko Y
    Oral Dis; 2020 Jan; 26(1):193-199. PubMed ID: 31705718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibromyalgia remains a controversial medical enigma.
    Adams SM
    Am Fam Physician; 2008 May; 77(9):1222; author reply 1222, 1224. PubMed ID: 18540486
    [No Abstract]   [Full Text] [Related]  

  • 10. Low-Dose Aripiprazole-Associated Sleepwalking in a Long-Term Zolpidem Treatment Patient With a Depressive Episode: A Case Report.
    Chu CW; Liang CS
    J Clin Psychopharmacol; 2019; 39(2):174-175. PubMed ID: 30624300
    [No Abstract]   [Full Text] [Related]  

  • 11. Two cases of burning mouth syndrome treated with olanzapine.
    Ueda N; Kodama Y; Hori H; Umene W; Sugita A; Nakano H; Yoshimura R; Nakamura J
    Psychiatry Clin Neurosci; 2008 Jun; 62(3):359-61. PubMed ID: 18588600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Combining Aripiprazole With Other Antipsychotics Worsen Psychosis?
    Mahgoub N
    J Clin Psychopharmacol; 2015 Aug; 35(4):470-1. PubMed ID: 26061610
    [No Abstract]   [Full Text] [Related]  

  • 13. Five Patients With Burning Mouth Syndrome in Whom an Antidepressant (Serotonin-Noradrenaline Reuptake Inhibitor) Was Not Effective, but Pregabalin Markedly Relieved Pain.
    Ito M; Tokura T; Yoshida K; Nagashima W; Kimura H; Umemura E; Tachibana M; Miyauchi T; Kobayashi Y; Arao M; Ozaki N; Kurita K
    Clin Neuropharmacol; 2015; 38(4):158-61. PubMed ID: 26166242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of depression with a neuro-thymoleptic combination in general practice].
    Schirmer G
    Psychiatr Prax; 1996 Mar; 23(2):99-100. PubMed ID: 8657820
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of Low-Dose Aripiprazole Monotherapy in the Treatment for an Adolescent With Obsessive-Compulsive Disorder.
    Sertdemir M; Akça ÖF
    Clin Neuropharmacol; 2017; 40(5):236-237. PubMed ID: 28922290
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effectiveness of a benzydamine rinse in the management of stomato-glossopyrosis].
    Mukics A; Bán A; Szabó G; Tóth V
    Fogorv Sz; 2005 Feb; 98(1):15-9. PubMed ID: 15853199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotransformation of amitriptyline in man: interaction with phenothiazines.
    Vandel S; Sandoz M; Vandel B; Bonin B; Allers G; Volmat R
    Neuropsychobiology; 1986; 15(1):15-9. PubMed ID: 2873526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of levosulpiride in burning mouth syndrome.
    Demarosi F; Tarozzi M; Lodi G; Canegallo L; Rimondini L; Sardella A
    Minerva Stomatol; 2007; 56(1-2):21-6. PubMed ID: 17287703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocytopenia in patients treated with multiple antipsychotics, including aripiprazole and quetiapine.
    Tomita T; Goto H; Chiba T; Tairabune T; Yoshida T; Tanaka K; Kudo K; Kohda Y
    Psychiatry Clin Neurosci; 2017 Jan; 71(1):71-72. PubMed ID: 27743457
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of amitriptyline for treatment of somatoform pain disorder in the orofacial region: A case series.
    Ikawa M; Yamada K; Ikeuchi S
    J Orofac Pain; 2006; 20(3):234-40. PubMed ID: 16913433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.